Cargando…

Precision oncology for intrahepatic cholangiocarcinoma in clinical practice

BACKGROUND: Advanced cholangiocarcinoma has a poor prognosis. Molecular targeted approaches have been proposed for patients after progression under first-line chemotherapy treatment. Here, molecular profiling of intrahepatic cholangiocarcinoma in combination with a comprehensive umbrella concept was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomczak, Aurelie, Springfeld, Christoph, Dill, Michael T., Chang, De-Hua, Kazdal, Daniel, Wagner, Ursula, Mehrabi, Arianeb, Brockschmidt, Antje, Luedde, Tom, Naumann, Patrick, Stenzinger, Albrecht, Schirmacher, Peter, Longerich, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390961/ https://www.ncbi.nlm.nih.gov/pubmed/35986087 http://dx.doi.org/10.1038/s41416-022-01932-1

Ejemplares similares

Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic Cholangiocarcinoma
por: Goeppert, Benjamin, et al.
Publicado: (2019)

Prostatic metastasis from intrahepatic cholangiocarcinoma
por: Tosev, Georgi, et al.
Publicado: (2018)

Knowledge bases and software support for variant interpretation in precision oncology
por: Borchert, Florian, et al.
Publicado: (2021)

Knowledge bases and software support for variant interpretation in precision oncology
por: Borchert, Florian, et al.
Publicado: (2021)

Molecular Subtypes and Precision Oncology in Intrahepatic Cholangiocarcinoma
por: Czauderna, Carolin, et al.
Publicado: (2021)

First proficiency testing for NGS‐based and combined NGS‐ and FISH‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma
por: Neumann, Olaf, et al.
Publicado: (2023)

Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma
por: Goeppert, Benjamin, et al.
Publicado: (2019)

Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing
por: Neumann, Olaf, et al.
Publicado: (2022)

Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma
por: Andrici, Juliana, et al.
Publicado: (2016)

Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities
por: Wehling, Cyrill, et al.
Publicado: (2021)

The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in Cholangiocarcinoma
por: Albrecht, Thomas, et al.
Publicado: (2021)

Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma
por: Tóth, Marcell, et al.
Publicado: (2021)

Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination
por: Schwab, Constantin, et al.
Publicado: (2022)

Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma: A Focus on Oncological Outcomes
por: Ratti, Francesca, et al.
Publicado: (2021)

Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma
por: Goeppert, Benjamin, et al.
Publicado: (2018)

Prolonged Survival of a Patient with Advanced-Stage Combined Hepatocellular-Cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2020)

Surgical management of primary liver cancers during the COVID-19 pandemic: overcoming the dilemma with standardization
por: Ramouz, Ali, et al.
Publicado: (2023)

Complex Liver Resections for Intrahepatic Cholangiocarcinoma
por: Reese, Tim, et al.
Publicado: (2021)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer
por: Goeppert, Benjamin, et al.
Publicado: (2015)

ASO Author Reflections: Optimizing the Oncological Outcome for Locally Advanced Intrahepatic Cholangiocarcinoma
por: Li, Jun, et al.
Publicado: (2020)

ASO Author Reflections: Geographic Disparities in Referral and Oncologic Outcomes in Intrahepatic Cholangiocarcinoma
por: Sutton, Thomas L., et al.
Publicado: (2021)

Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI
por: Palm, Viktoria, et al.
Publicado: (2018)

Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies
por: Kriegsmann, Mark, et al.
Publicado: (2019)

Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder Cancer
por: Albrecht, Thomas, et al.
Publicado: (2021)

Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma
por: Nickkholgh, A., et al.
Publicado: (2019)

Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma: A meta-analysis
por: Ma, Ka Wing, et al.
Publicado: (2019)

Textbook oncologic outcomes and regionalization among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma
por: Munir, Muhammad M., et al.
Publicado: (2022)

The Oncologic Implications of Tumor Multiplicity in Intrahepatic Cholangiocarcinoma: Its Prognostic Value Might Be Underestimated
por: Yoon, So Jeong, et al.
Publicado: (2023)

Two Varieties of Intrahepatic Cholangiocarcinoma
por: Nagorney, David M.
Publicado: (1994)

Intrahepatic Cholangiocarcinoma with Sarcomatous Changes
por: Inoue, Yoshiyuki, et al.
Publicado: (2012)

Serum Markers of Intrahepatic Cholangiocarcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2013)

Intrahepatic cholangiocarcinoma: current perspectives
por: Buettner, Stefan, et al.
Publicado: (2017)

Intratumoral heterogeneity of intrahepatic cholangiocarcinoma
por: Walter, Dirk, et al.
Publicado: (2017)

Molecular heterogeneity in intrahepatic cholangiocarcinoma
por: Ahn, Keun Soo, et al.
Publicado: (2020)

Recurrent Intrahepatic Cholangiocarcinoma – Review
por: Bekki, Yuki, et al.
Publicado: (2021)

Stereotactic radiotherapy for intrahepatic cholangiocarcinoma
por: Borakati, Aditya, et al.
Publicado: (2022)

Surgical Aspects of Intrahepatic Cholangiocarcinoma
por: Kupietzky, Amram, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s3p3184auj2j0bakjgg3abt36i